专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20170091393A1 Practitioner Network and Patient Coordinated Healthcare System 审中-公开
公开(公告)号：US20170091393A1
公开(公告)日：2017-03-30
申请号：US15275978
申请日：2016-09-26
申请人： Hasan Ali Muhammad , David MacLeod
发明人： Hasan Ali Muhammad , David MacLeod
IPC分类号： G06F19/00 , H04L29/06 , G06F21/62
CPC分类号： G06F19/3481 , G06F21/316 , G06F21/6245 , G06F2221/2133 , G16H10/60 , G16H40/63 , H04L63/104 , H04L63/105 , H04L2209/88
摘要： A practitioner network and patient coordinated healthcare system devised to enable secure and private handling of a patient history as a single Electronic Coordinated Care Portfolio (“ECCP”) accessible through a patient portal via network. Multiple caregivers are able to access partitions in a patient portal comprising a plurality of COMMs for access, upload, and, for some users, download of relevant healthcare information. Access and privileges at each of the plurality of COMMs is controllable by assignment of vertical access tiers to users. Caregivers are thus enabled a holistic understanding of care provision across all caregivers for a particular patient, while patient privacy is protected. The ECCP is encodable as a unique file format to which specific security protocols are enabled and sharing of confidential data is protectable, accessible between authorized users only.

2. 发明申请

US20170124266A1 Method for Practitioner Network and Appointment Management System 审中-公开
公开(公告)号：US20170124266A1
公开(公告)日：2017-05-04
申请号：US15342051
申请日：2016-11-02
申请人： Muhammad Ali Hasan , David MacLeod
发明人： Muhammad Ali Hasan , David MacLeod
IPC分类号： G06F19/00 , G06F3/0482
CPC分类号： G16H40/20 , G01C21/3407 , G01C21/362 , G06F3/04817 , G06F3/04842 , G06Q10/02 , G16H10/60
摘要： A practitioner network and appointment management system is presented that coordinates between end users and practitioners to enable networked appointment scheduling and management. The system includes an end user side and a practitioner side. End user side enables control of a scalable interactive map whereon practitioner data points are displayable by medical discipline. Practitioner first order data (including time to availability) is visually cued. Selection of a practitioner data point enables end user entry to a practitioner queue, which updates practitioner first order data across the network. Patient data is automatically transferrable to the practitioner queue by secure protocol. Practitioner side enables access of practitioner queue and selection of patients occupying designated slots therein to view associated patient data. Patient locations are displayable to practitioner for in-person visits. Practitioners can transfer patients into other practitioner queues. HIPPA compliant secure data exchange and financial transactions are enabled across the network.

3. 发明申请

US20110117030A1 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections 有权
标题翻译：气雾化磷霉素/氨基糖苷组合治疗细菌性呼吸道感染
公开(公告)号：US20110117030A1
公开(公告)日：2011-05-19
申请号：US12967645
申请日：2010-12-14
申请人： William Baker , David MacLeod
发明人： William Baker , David MacLeod
IPC分类号： A61K9/12 , A61K31/665 , A61P31/04 , A61P11/00
CPC分类号： A61K31/7008 , A61K9/0075 , A61K9/0078 , A61K9/19 , A61K31/665 , A61K31/7036 , A61K45/06 , A61M11/00 , A61M11/005 , B65D85/00 , Y02A50/473 , Y10S514/851 , Y10T436/107497 , A61K2300/00
摘要： A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of fosfomycin plus tobramycin is able to inhibit susceptible bacteria. Fosfomycin and tobramycin are formulated separately in a dual ampoule such that when reconstituted, the pH is between 4.5 and 8.0 or as a dry powder. The method for treatment of respiratory tract infections by a formulation delivered as an aerosol having mass median aerodynamic diameter predominantly between 1 to 5μ, produced by a jet or ultrasonic nebulizer (or equivalent) or dry powder inhaler.
摘要翻译：描述了通过气雾化递送的磷霉素加妥布霉素组合制剂。含有有效量的磷霉素加妥布霉素的浓缩磷霉素妥布霉素组合制剂能够抑制易感细菌。磷霉素和妥布霉素分别配制在双安瓿中，使得当重新配制时，pH值在4.5-8.0之间或干粉末。用喷雾或超声雾化器（或等效的）或干粉吸入器产生的具有主要在1至5μ之间的质量中值空气动力学直径的气溶胶递送的制剂治疗呼吸道感染的方法。

4. 发明授权

US09196076B1 Method for producing two-dimensional animated characters 有权
标题翻译：二维动画角色的制作方法
公开(公告)号：US09196076B1
公开(公告)日：2015-11-24
申请号：US13297751
申请日：2011-11-16
申请人： David MacLeod
发明人： David MacLeod
IPC分类号： G06T15/10 , G06T13/80
CPC分类号： G06T13/80
摘要： A method for producing a two-dimensional (2D) animated character sequence is provided. The method includes producing a set of 2D drawings that represent one or more views of the body parts of the character being represented, analyzing an animated sequence of a three-dimensional (3D) armature in order to determine the motion of an animated character in 3D space over time, using a selection operation to determine which particular view of each body part to use to best represent that body part at any particular moment in time in the animated sequence, performing a projection operation for each bone of the armature in order to determine where, on a 2D plane, the selected drawing should be placed in a 2D animation frame, and assembling the selected body part drawings in order to produce the frames of a 2D animated character.
摘要翻译：提供了一种制作二维（2D）动画角色序列的方法。该方法包括产生一组2D绘图，其表示所表示的角色的身体部分的一个或多个视图，分析三维（3D）电枢的动画序列，以便确定3D中的动画角色的运动随着时间的推移，使用选择操作来确定每个身体部位的特定视图用于在动画序列中的任何特定时刻最佳地表示身体部位，对衔铁的每个骨骼执行投影操作，以便确定其中，在2D平面上，所选择的图形应该被放置在2D动画框架中，并且组装所选择的身体部位图以便产生2D动画角色的帧。

5. 发明授权

US08980226B2 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections 有权
标题翻译：气雾剂磷霉素/氨基糖苷组合用于治疗细菌性呼吸道感染
公开(公告)号：US08980226B2
公开(公告)日：2015-03-17
申请号：US13616544
申请日：2012-09-14
申请人： William Baker , David MacLeod
发明人： William Baker , David MacLeod
IPC分类号： A61K9/12 , A61K9/14 , A61K31/7008 , A61K9/00 , A61K9/19 , A61K31/665 , A61K31/7036 , A61K45/06 , A61M11/00 , B65D85/00
CPC分类号： A61K31/7008 , A61K9/0075 , A61K9/0078 , A61K9/19 , A61K31/665 , A61K31/7036 , A61K45/06 , A61M11/00 , A61M11/005 , B65D85/00 , Y02A50/473 , Y10S514/851 , Y10T436/107497 , A61K2300/00
摘要： A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of fosfomycin plus tobramycin is able to inhibit susceptible bacteria. Fosfomycin and tobramycin are formulated separately in a dual ampoule such that when reconstituted, the pH is between 4.5 and 8.0 or as a dry powder. The method for treatment of respiratory tract infections by a formulation delivered as an aerosol having mass median aerodynamic diameter predominantly between 1 to 5μ, produced by a jet or ultrasonic nebulizer (or equivalent) or dry powder inhaler.
摘要翻译：描述了通过气雾化递送的磷霉素加妥布霉素组合制剂。含有有效量的磷霉素加妥布霉素的浓缩磷霉素妥布霉素组合制剂能够抑制易感细菌。磷霉素和妥布霉素分别配制在双安瓿中，使得当重新配制时，pH值在4.5-8.0之间或干粉末。用喷雾或超声雾化器（或等效的）或干粉吸入器产生的具有主要在1至5μ之间的质量中值空气动力学直径的气溶胶递送的制剂治疗呼吸道感染的方法。

6. 发明授权

US08409549B2 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections 有权
标题翻译：气雾剂磷霉素/氨基糖苷组合用于治疗细菌性呼吸道感染
公开(公告)号：US08409549B2
公开(公告)日：2013-04-02
申请号：US13085576
申请日：2011-04-13
申请人： William Baker , David MacLeod
发明人： William Baker , David MacLeod
IPC分类号： A61K9/12 , A61K9/14 , A61K31/69 , A61K31/665 , A01N25/02 , A01N57/00 , C07H11/00 , C07H17/00 , C07G15/00
CPC分类号： A61K31/7008 , A61K9/0075 , A61K9/0078 , A61K9/19 , A61K31/665 , A61K31/7036 , A61K45/06 , A61M11/00 , A61M11/005 , B65D85/00 , Y02A50/473 , Y10S514/851 , Y10T436/107497 , A61K2300/00
摘要： A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of fosfomycin plus tobramycin is able to inhibit susceptible bacteria. Fosfomycin and tobramycin are formulated separately in a dual ampoule such that when reconstituted, the pH is between 4.5 and 8.0 or as a dry powder. The method for treatment of respiratory tract infections by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 μ, produced by a jet or ultrasonic nebulizer (or equivalent) or dry powder inhaler.
摘要翻译：描述了通过气雾化递送的磷霉素加妥布霉素组合制剂。含有有效量的磷霉素加妥布霉素的浓缩磷霉素妥布霉素组合制剂能够抑制易感细菌。磷霉素和妥布霉素分别配制在双安瓿中，使得当重新配制时，pH值在4.5-8.0之间或干粉末。通过喷射或超声雾化器（或等效的）或干粉吸入器产生的具有主要在1至5μ之间的质量中等平均直径的气溶胶递送的制剂治疗呼吸道感染的方法。

7. 发明申请

US20140201190A1 Method and system to provide composite view of components 有权
标题翻译：方法和系统提供组合视图的组件
公开(公告)号：US20140201190A1
公开(公告)日：2014-07-17
申请号：US11021588
申请日：2004-12-22
申请人： Hillary Ebenstein , Giles Goodwin , George Penston , Gregory Guttmann , David MacLeod , Jeff Althoff
发明人： Hillary Ebenstein , Giles Goodwin , George Penston , Gregory Guttmann , David MacLeod , Jeff Althoff
IPC分类号： G06F17/30
CPC分类号： G06F17/30451 , G06F17/30106 , G06F17/30112 , G06F17/30277 , G06F17/30412 , G06F17/30554 , G06F17/30566 , G06F17/30991
摘要： Systems and methods for defining a composite view and using the definition of the composite view to obtain, aggregate, analyze, and present data from a variety of data sources to a user. These systems and methods may allow for the definition of a visual framework to aggregate and display related data. This visual framework, or composite view, may in turn be composed of a master view and a set of subviews, each of which may display data collected from a particular data source according to a particular format. By interacting with the master view data from a variety of data sources can be displayed.
摘要翻译：用于定义复合视图并使用复合视图的定义的系统和方法，以从用户的各种数据源获取，聚合，分析和呈现数据。这些系统和方法可以允许定义可视化框架来聚合和显示相关数据。该视觉框架或复合视图可以由主视图和一组子视图组成，每个视图可以根据特定格式显示从特定数据源收集的数据。通过与主视图进行交互可以显示来自各种数据源的数据。

8. 发明申请

US20130166311A1 System and Method for Provisioning and Deploying a Virtual Appliance to Implement Enterprise Solutions 审中-公开
标题翻译：用于配置和部署虚拟设备以实施企业解决方案的系统和方法
公开(公告)号：US20130166311A1
公开(公告)日：2013-06-27
申请号：US13332675
申请日：2011-12-21
申请人： Michael Stock , David MacLeod , Rob Campolieto , Bill Monday , Darin Osburn , Tom Reising , Michael Saxbury , Brent Schmoker , Calvin Griffin , Monte Hartman , Terry Mayer
发明人： Michael Stock , David MacLeod , Rob Campolieto , Bill Monday , Darin Osburn , Tom Reising , Michael Saxbury , Brent Schmoker , Calvin Griffin , Monte Hartman , Terry Mayer
IPC分类号： G06F9/44 , G06Q50/22 , G06Q40/08
CPC分类号： G06Q50/22 , G06F8/63 , G06F8/65 , G06F9/45558 , G06F2009/45562 , G06Q40/08
摘要： A reference architecture embodies a common, consistent, known best practice base reference architecture and configuration that may then be used for cloning out for the base of every customer environment. Given this base, the service provider is able to control the full functionality solution layer to provide the platform for consistent monitoring, patching, upgrading, etc. Accordingly, the service provider's application solution is an integrated appliance that can contain whatever is necessary at the solution layer to allow the service provider to remotely (or within the hosting center) support, maintain and gather key system metrics to promote optimal customer performance, decrease cost of implementation/support/ownership and vastly increase service offering base.
摘要翻译：参考架构体现了一种常见的，一致的，已知的最佳实践基准参考架构和配置，然后可以将其用于克隆出每个客户环境的基础。鉴于此基础，服务提供商能够控制完整的功能解决方案层，以提供一致的监控，修补，升级等平台。因此，服务提供商的应用解决方案是集成设备，可以包含解决方案中必需的任何内容层，允许服务提供商远程（或在托管中心内）支持，维护和收集关键系统度量，以促进最佳客户绩效，降低实施/支持/所有权成本，并大大增加服务提供基础。

9. 发明申请

US20130071442A1 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections 有权
标题翻译：气雾化磷霉素/氨基糖苷组合治疗细菌性呼吸道感染
公开(公告)号：US20130071442A1
公开(公告)日：2013-03-21
申请号：US13616544
申请日：2012-09-14
申请人： William Baker , David MacLeod
发明人： William Baker , David MacLeod
IPC分类号： A61K31/7008 , A61M11/00 , A61K31/665 , B65D85/00
CPC分类号： A61K31/7008 , A61K9/0075 , A61K9/0078 , A61K9/19 , A61K31/665 , A61K31/7036 , A61K45/06 , A61M11/00 , A61M11/005 , B65D85/00 , Y02A50/473 , Y10S514/851 , Y10T436/107497 , A61K2300/00
摘要： A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of fosfomycin plus tobramycin is able to inhibit susceptible bacteria. Fosfomycin and tobramycin are formulated separately in a dual ampoule such that when reconstituted, the pH is between 4.5 and 8.0 or as a dry powder. The method for treatment of respiratory tract infections by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5μ, produced by a jet or ultrasonic nebulizer (or equivalent) or dry powder inhaler.
摘要翻译：描述了通过气雾化递送的磷霉素加妥布霉素组合制剂。含有有效量的磷霉素加妥布霉素的浓缩磷霉素妥布霉素组合制剂能够抑制易感细菌。磷霉素和妥布霉素分别配制在双安瓿中，使得当重新配制时，pH值在4.5-8.0之间或干粉末。通过喷射或超声雾化器（或等效的）或干粉吸入器产生的具有主要在1至5μ之间的质量中等平均直径的气溶胶递送的制剂治疗呼吸道感染的方法。

10. 发明申请

US20110189103A1 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections 有权
标题翻译：气雾化磷霉素/氨基糖苷组合治疗细菌性呼吸道感染
公开(公告)号：US20110189103A1
公开(公告)日：2011-08-04
申请号：US13085576
申请日：2011-04-13
申请人： William Baker , David MacLeod
发明人： William Baker , David MacLeod
IPC分类号： A61K9/12 , A61P31/04 , A61K31/7036
CPC分类号： A61K31/7008 , A61K9/0075 , A61K9/0078 , A61K9/19 , A61K31/665 , A61K31/7036 , A61K45/06 , A61M11/00 , A61M11/005 , B65D85/00 , Y02A50/473 , Y10S514/851 , Y10T436/107497 , A61K2300/00
摘要： A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of fosfomycin plus tobramycin is able to inhibit susceptible bacteria. Fosfomycin and tobramycin are formulated separately in a dual ampoule such that when reconstituted, the pH is between 4.5 and 8.0 or as a dry powder. The method for treatment of respiratory tract infections by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5μ, produced by a jet or ultrasonic nebulizer (or equivalent) or dry powder inhaler.
摘要翻译：描述了通过气雾化递送的磷霉素加妥布霉素组合制剂。含有有效量的磷霉素加妥布霉素的浓缩磷霉素妥布霉素组合制剂能够抑制易感细菌。磷霉素和妥布霉素分别配制在双安瓿中，使得当重新配制时，pH值在4.5-8.0之间或干粉末。通过喷射或超声雾化器（或等效的）或干粉吸入器产生的具有主要在1至5μ之间的质量中等平均直径的气溶胶递送的制剂治疗呼吸道感染的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式